LULU vs MELI: Which Is the Better Buy?

Side-by-side comparison of Lululemon Athletica Inc. and MercadoLibre, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Lululemon Athletica Inc. Β· Consumer Cyclical
$111.77
+45.0% upside to fair value
Grade B High Quality
VS
MercadoLibre, Inc. Β· Consumer Cyclical
$1,635.15
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
LULU trades at a lower forward P/E (9.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric LULU MELI
Current Price $111.77 $1,635.15
Fair Value Estimate $162.07 $2,370.97
Upside to Fair Value +45.0% +45.0%
Market Cap $12.7B $82.9B
Forward P/E 9.1x 43.2x
EV / EBITDA 5.1x 27.0x
Price / Sales 1.1x 2.6x
Price / FCF 9.9x 7.7x
Revenue Growth YoY +4.3% +49.0%
Gross Margin 55.7% 43.9%
Operating Margin 18.2% 9.6%
Return on Equity 31.3% 29.6%
Dividend Yield 0% 0%
FCF Yield 10.08% 12.92%
Analyst Consensus Hold Strong Buy
Investment Thesis
LULU β€” Lululemon Athletica Inc.
Lululemon Athletica Inc. operates in the premium athletic apparel retail sector, leveraging a strong brand and a durable competitive moat driven by product innovation and global expansion, particularly in China. The company has demonstrated solid capital allocation with organic growth and buybacks, though it faces near-term earnings pressure with a 38% decline in quarterly earnings year-over-year…
MELI β€” MercadoLibre, Inc.
MercadoLibre is a leading Latin American e-commerce and fintech platform with a durable competitive moat driven by its integrated logistics and financial services stack. The company commands approximately 30 to 35 percent market share in e-commerce and over 30 percent in online payments in key markets like Brazil. It is founder-influenced with a long-tenured management team and reinvests heavily …
Accumulation Zones
Metric LULU MELI
Zone Low $121.55 $1,778.23
Zone High $137.76 $2,015.32
In Buy Zone? Yes Yes
← LULU Research    MELI Research β†’    All Research